A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel ...

A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel ...

Acute myeloid leukemia (AML) is an aggressive blood cancer that remains difficult to treat. While targeted therapies have ...

Researchers used CRISPR to remove the CD33 protein from donor stem cells, protecting healthy blood cells from therapies that target leukemia. In a 30-patient trial, the edited cells rebuilt blood ...

A new trial has been able to discover that a highly sensitive bone marrow test could change the way diagnosis and treatment of acute myeloid leukemia are done. It can help improve the lives of ...

"This specific formulation of daunorubicin and cytarabine is not the right choice," expert ...

OPTI-AML, a sub-study of Beat AML, compared the standard 28-day venetoclax schedule with a 14-day schedule, both given with ...

Add Yahoo as a preferred source to see more of our stories on Google. Tatiana Schlossberg's surprising revelation that she is battling terminal cancer has put a spotlight on the type of cancer with ...

Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using ...

The exact cause of acute myeloid leukemia (AML) is unclear, but risk factors can include older age, radiation exposure, smoking, certain genetic conditions, and more. Acute myeloid leukemia (AML) is a ...